Antares Pharma, Inc.

Swiss National Bank MJC

Report date

3/31/2022

Quarter

2022 Q1

Filed

5/9/2022

Shares

382,000

Value ($000)

1,566

Weight

0.0%

2013 Q4 - 2022 Q1 (13 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2022 Q1	5/9/2022	1,566	0.0%	382,000	3/31/2022
2021 Q4	2/8/2022	1,265	0.0%	354,300	12/31/2021
2021 Q3	11/8/2021	1,290	0.0%	354,300	9/30/2021
2021 Q2	8/6/2021	1,522	0.0%	349,000	6/30/2021
2021 Q1	5/7/2021	1,487	0.0%	361,800	3/31/2021
2020 Q4	2/5/2021	1,422	0.0%	356,500	12/31/2020
2020 Q3	11/9/2020	963	0.0%	356,500	9/30/2020
2020 Q2	8/5/2020	952	0.0%	346,100	6/30/2020
2020 Q1	5/8/2020	710	0.0%	300,700	3/31/2020
2019 Q4	2/6/2020	1,394	0.0%	296,500	12/31/2019
2014 Q2	8/6/2014	367	0.0%	137,300	6/30/2014
2014 Q1	5/6/2014	481	0.0%	137,300	3/31/2014
2013 Q4	1/31/2014	489	0.0%	109,100	12/31/2013